immunotherapy

AstraZeneca shares data from HIMALAYA, MATTERHORN Phase III studies at ESMO Asia Congress 2023

Read more

DCGI approves KEYTRUDA to treat triple negative breast cancer, renal cell carcinoma

Read more

Israeli researchers develop bio-sensing technology to predict cancer treatment response

Read more

Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India: GlobalData

Read more

NIH study advances personalised immunotherapy for metastatic breast cancer

Read more

2021 is a key year for personalised neoantigen immuno-oncology therapeutics: GlobalData

Read more

ImmunityBio and NantKwest announce merger

Read more

US FDA grants orphan drug designation to oNKord from Glycostem for multiple myeloma

Read more

Bristol Myers Squibb clinches acquisition of Forbius

Read more

Gilead and Jounce Therapeutics sign exclusive license pact for novel immunotherapy program

Read more